Cooper Vascular and Endovascular Surgery is involved in a wide variety of clinical trials related to your vascular health. Being a participant in a study may allow the use of advanced devices that are pending FDA approval and which are not available to patients outside of the study. If you would like more information about our clinical trials or think that you might qualify to participate please make an appointment with Cooper Vascular Surgery to discuss your options. Our physicians will be able to determine your eligibility for a particular clinical trial based on a physical examination and a discussion with you.

Open Vascular and Endovascular Clinical Trials 

CONTINuous Infra-Inguinal Stenting Using the Bard LifeStent® VascUlar Stent SysteMs (“CONTINUUM”) - Jeffrey Carpenter, MD
This study is a prospective, multi-center, single-arm, non-randomized study enrolling subjects with lifestyle-limiting claudication or ischemic rest pain attributable to lesions in the infra-inguinal segment (superficial femoral artery (SFA) and/or proximal popliteal artery) that are amenable to treatment by percutaneous transluminal angioplasty and stenting.

Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System - Jose Trani, MD
To study the safety and effectiveness of the Nellix System for Endovascular Abdominal Aortic Aneurysm (AAA) repair

Zenith® Low Profile AAA Endovascular Graft Clinical Study – Francis J. Caputo, MD
The objective of the study is to evaluate the safety and effectiveness of the Zenith Low Profile AAA Endovascular Graft used in conjunction with the Zenith Spiral-Z AAA Iliac Leg Graft.